文献速递心血管胸部CT

心外膜脂肪组织、冠状动脉斑块进展与主要不良心血管事件:一项多中心研究

Epicardial Adipose Tissue, Coronary Plaque Progression, and Major Adverse Cardiovascular Events: A Multicenter Study.
PubMed 文献 · JACC Cardiovasc Imaging · 2026-03-10

基于PARADIGM注册研究,对773例患者行系列冠状动脉CT血管造影,评估心外膜脂肪体积(EATv)与斑块体积、斑块总体积百分比(PAV)及斑块进展(PP)的关系。CAD患者EATv显著高于无CAD者(95 cm³ vs 83.5 cm³,P<0.001);EATv最高三分位组PP和快速斑块进展(RPP)患病率均高于最低三分位组;PP和RPP患者10年无MACE生存率更低(P=0.006和P<0.001)。高EATv与CAD存在及进展独立相关。

要点

  • CAD患者EATv显著高于无CAD者(95 cm³ vs 83.5 cm³,P<0.001)。
  • EATv最高三分位组斑块进展和快速斑块进展患病率均高于最低三分位组。
  • PP和RPP患者10年无MACE生存率更低(log-rank P=0.006和P<0.001)。

核心结论

  • 高EATv与CAD存在及斑块进展独立相关,提示其可能作为风险分层标志和更早期或更强化治疗的治疗靶点。

研究设计与样本

  • 来自PARADIGM注册研究的多中心研究,纳入773例患者(平均年龄62±9岁,女性324例[43%]),采用系列冠状动脉CT血管造影评估斑块体积、PAV和斑块进展,RPP定义为年PAV增加≥1%,测量EATv和晚期斑块特征,CAD定义为任何斑块。

关键影像表现/征象

  • CAD患者EATv为95 cm³(Q1-Q3:72.5-127 cm³),无CAD者为83.5 cm³(Q1-Q3:63-112.8 cm³),P<0.001。
  • EATv最高三分位组(T3)斑块体积进展较T1更显著(P=0.001)。
  • EATv最高三分位组(T3)PAV进展较T1更显著(P=0.028)。
  • EATv最高三分位组(T3)钙化成分进展较T1更显著(P=0.025)。
  • EATv最高三分位组(T3)非钙化成分进展较T1更显著(P=0.022)。

诊断标准与关键数值

  • 快速斑块进展(RPP)定义为年PAV增加≥1%。
  • 斑块进展(PP)患病率:T1 78.9% vs T2 83.9% vs T3 88.5%,P=0.013。
  • 快速斑块进展(RPP)患病率:T1 25.2% vs T2 32.3% vs T3 36.4%,P=0.021。
  • CAD定义为任何斑块。

临床应用与阅片要点

  • 在系列冠状动脉CT血管造影中测量EATv,可辅助识别斑块进展风险较高的患者。
  • EATv较高者随访中斑块体积、PAV及钙化和非钙化成分进展更明显,阅片时可结合EATv评估。
  • PP和RPP与10年无MACE生存率降低相关(log-rank P=0.006和P<0.001),报告斑块进展具有预后意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Epicardial adipose tissue (EAT) is associated with coronary artery disease (CAD), but its relationship with plaque progression (PP)-a predictor of major adverse cardiovascular events (MACE)-remains unclear.

OBJECTIVES: This study examines the interplay between EAT, PP, and subsequent MACE.

METHODS: From the PARADIGM (Progression of Atherosclerotic Plaque Determined by Computed Tomographic Angiography Imaging) registry, serial coronary computed tomography angiography assessed plaque volume (PV), percent atheroma volume (PAV), and PP. Rapid plaque progression (RPP) was defined as annual PAV increase ≥1%. EAT volume (EATv) and advanced plaque characteristics were measured. CAD was defined as any plaque. Multivariable models assessed associations between EATv, plaque, PP, and RPP. The prognostic value of PP and RPP for MACE was evaluated.

RESULTS: Among 773 patients (mean age 62 ± 9 years; 324 women [43%]), those with CAD had significantly higher EATv than did those without CAD (95 cm3 [Q1-Q3: 72.5-127 cm3] vs 83.5 cm3 [Q1-Q3: 63-112.8 cm3]; P < 0.001). Progression of PV, PAV, and calcified and noncalcified plaque components was significantly greater in the highest (third) EATv tertile (T3) than in T1 (PV: P = 0.001; PAV: P = 0.028; calcified component: P = 0.025; noncalcified component: P = 0.022). The prevalences of PP (T1: 78.9% vs T2: 83.9% vs T3: 88.5%; P = 0.013) and RPP (T1: 25.2% vs T2: 32.3% vs T3: 36.4%; P = 0.021) also increased across EATv tertiles. In multivariable analyses, high EATv was independently associated with plaque, PP, and RPP across 2 different models adjusted for age, sex, body mass index, diabetes, dyslipidemia, hypertension, hypertriglyceridemia, smoking, and statin therapy. Patients with PP and RPP had lower 10-year MACE-free survival (log-rank; P = 0.006 and log-rank; P < 0.001, respectively).

CONCLUSIONS: High EATv is independently associated with CAD presence and progression, underscoring its potential as a marker for risk stratification and a therapeutic target for earlier or more intensive treatment.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Filtz A, Lorenzatti D, Scotti A, et al. Epicardial Adipose Tissue, Coronary Plaque Progression, and Major Adverse Cardiovascular Events: A Multicenter Study. JACC Cardiovasc Imaging. 2026. PMID: 41805274. doi:10.1016/j.jcmg.2026.02.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。